Importantly, combining TIGIT+PD-L1 blockade with anti-GD2 was recently shown to be effective also in other neuroblastoma models, and recent clinical trials combining TIGIT and PD-1/PD-L1 blockade have produced encouraging results in advanced solid tumors in adults.71 Here, CD274 is linked to neuroblastoma.